Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Authors

• Christoph U Correll
• John Lauriello

Publication/Presentation Date

1-1-2018

Abstract

Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for patients with serious mental illness but are underused. Watch this Webcast to learn how to identify patients who may benefit from using LAIs, monitor treatment adherence, and use LAIs safely and effectively in patients with schizophrenia and related disorders.

Volume

79

Issue

1

ISSN

1555-2101

Published In/Presented At

Correll, C. U., & Lauriello, J. (2018). Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?. The Journal of clinical psychiatry, 79(1), AL17017WC1C. https://doi.org/10.4088/JCP.AL17017WC1C

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

29505193

Department(s)

Administration and Leadership

Document Type

Article